Expert opinion on NSCLC small specimen biomarker testing - Part 1: Tissue collection and management.
Published in Virchows Archiv : an international journal of pathology • Sep 1, 2022
Authors:,,
Frédérique Penault-Llorca
Keith M Kerr
Pilar Garrido
Abstract
Biomarker testing is crucial for treatment selection in advanced non-small cell lung cancer (NSCLC). However, the quantity of available tissue often presents a key constraint for patients with advanced disease, where minimally invasive tissue biopsy typically returns small samples. In Part 1 of this...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!